Middle East News Digest
SEE OTHER BRANDS

Your daily news update on the Middle East

Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on April 3, 2025

AGII Boosts Contract Performance with Decentralized AI Monitoring Frameworks

AGII Boosts Contract Performance with Decentralized AI Monitoring Frameworks

Advanced AI-driven frameworks enhance the reliability, speed, and scalability of smart contracts across decentralized ecosystems. SEATTLE, WA, UNITED STATES, April 3, 2025 /⁨EINPresswire.com⁩/ -- AGII has introduced decentralized AI monitoring frameworks …

E2SOL Solar-Powered Utility Median Barriers on Dubai Highways

E2SOL Solar-Powered Utility Median Barriers on Dubai Highways

DUBAI'S SOLAR POWER HIGHWAY MICROGRID POTENTIAL PROVIDENCE, RI, UNITED STATES, April 3, 2025 /⁨EINPresswire.com⁩/ -- E2SOL Solar-Powered Utility Median Barriers on Dubai Highways Rendering of an E2SOL Integrated Highway Median PV Microgrid System to …

BetterLife Pharma Appoints Corporate Advisor

BetterLife Pharma Appoints Corporate Advisor

VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed André Beaudry as Corporate …

Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition affecting five to 12% of the population globally TMJ causes pain and stiffness in the jaw, making it …

Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome

Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome

MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria Rare Pediatric Designation granted MNV-201 is also being studied in a Phase Ib for low-risk …

Duke Robotics Provides Update on Progress with Elbit Systems Regarding “Birds of Prey” Stabilized Weapons Drone System

Duke Robotics Provides Update on Progress with Elbit Systems Regarding “Birds of Prey” Stabilized Weapons Drone System

FT. LAUDERDALE, FL, April 03, 2025 (GLOBE NEWSWIRE) -- Duke Robotics Corp. (OTCQB: DUKR) ("Duke Robotics" or the "Company"), a leader in advanced robotics technology and autonomous drone solutions, today provided an update regarding developments in its …

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified …

GFG Announces C$2.5 Million Flow-Through Private Placement

GFG Announces C$2.5 Million Flow-Through Private Placement

SASKATOON, Saskatchewan, April 03, 2025 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) announces a private placement of premium flow-through units ("Premium Units") to raise gross proceeds of up to C$2.5 million …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service